Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 296Carcinoma, Hepatocellular 213Stomach Neoplasms 155Pancreatic Neoplasms 155Rectal Neoplasms 114Esophageal Neoplasms 84Colonic Neoplasms 78Esophageal Squamous Cell Carcinoma 52Cholangiocarcinoma 48Liver Neoplasms 47Biliary Tract Neoplasms 36Neoplasms 31Breast Neoplasms 31Neoplasm Metastasis 28Carcinoma, Non-Small-Cell Lung 27Gastrointestinal Neoplasms 26Lung Neoplasms 20Disease 18Prostatic Neoplasms 17Uterine Cervical Neoplasms 16Recurrence 16Ovarian Neoplasms 14Colorectal Neoplasms, Hereditary Nonpolyposis 13Endometrial Neoplasms 12Head and Neck Neoplasms 11Adenocarcinoma Of Esophagus 11Gallbladder Neoplasms 10Colonic Polyps 10Anus Neoplasms 10Melanoma 9

Interventions

tislelizumab 1S 1 (combination) 1Paclitaxel 1Hyperthermic Intraperitoneal Chemotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Gastric Cancer Peritoneal Metastases × Gastrointestinal × Clear all
NCT07304258 2025-12-26

A Prospective, Phase II Clinical Study of HIPEC Combined With NIPS and Tislelizumab Conversion Therapy for Gastric Cancer With Peritoneal Metastasis With Positive Cytology Alone or PCI Score ≤10

Hebei Medical University

Phase 2 Not yet recruiting
30 enrolled
Gastrointestinal

Gastric Cancer Peritoneal Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡